The presentation objectives for this webinar will include: identifying strategies to better assist clinicians in understanding wellness, prevention and chronic disease management by using Reticulocycte Hemoglobin or RET-He. We will also discuss the RET-He threshold or cutoff values for defining iron availability in the apparently healthy reference population, as well as in populations at high risk for iron deficiency and iron deficiency anemia. Additionally, we will present published clinical studies that demonstrate the value of RET-He in monitoring iron deficiency, iron deficiency anemia, and Erythropoietin Stimulating therapy or ESA in key patient populations.

DURATION: 40 min


Click on the link below to receive the certificate of participation issued by Sysmex for viewing this webinar.

Our website uses cookies to improve your browsing experience. By continuing to browse, you agree to our Privacy and Cookies Policy.